Bosh sahifaCRNX • NASDAQ
add
Crinetics Pharmaceuticals Inc
29,96 $
Seans yopilganidan keyin:(0,00%)0,00
29,96 $
Yopilgan:27-iyn, 17:20:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
29,99 $
Kunlik diapazon
29,59 $ - 30,85 $
Yillik diapazon
24,10 $ - 62,53 $
Bozor kapitalizatsiyasi
2,81 mlrd USD
Oʻrtacha hajm
685,24 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 361,00 ming | -43,59% |
Joriy xarajat | 35,53 mln | 70,57% |
Sof foyda | -96,77 mln | -44,59% |
Sof foyda marjasi | -26,81 ming | -156,34% |
Har bir ulushga tushum | -1,04 | -11,83% |
EBITDA | -110,48 mln | -51,23% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,27 mlrd | 41,42% |
Jami aktivlari | 1,36 mlrd | 39,17% |
Jami passivlari | 107,33 mln | 3,98% |
Umumiy kapital | 1,25 mlrd | — |
Tarqatilgan aksiyalar | 93,68 mln | — |
Narxi/balansdagi bahosi | 2,24 | — |
Aktivlardan daromad | -19,92% | — |
Kapitaldan daromad | -20,77% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -96,77 mln | -44,59% |
Operatsiyalardan naqd pul | -88,45 mln | -67,35% |
Sarmoyadan naqd pul | -85,96 mln | -27 919,09% |
Moliyadan naqd pul | 4,44 mln | -98,87% |
Naqd pulning sof oʻzgarishi | -169,98 mln | -149,84% |
Boʻsh pul | -47,18 mln | -69,57% |
Haqida
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018. Wikipedia
Tashkil etilgan
18-noy, 2008
Sayt
Xodimlar soni
437
